What obstacles there are to the drug, low dose naltrexone (LDN), being offered more widely to people with multiple sclerosis.

Answered Asked by Ken Macintosh Lab Lodged 1 Feb 2010

The question

To ask the Scottish Executive what obstacles there are to the drug, low dose naltrexone (LDN), being offered more widely to people with multiple sclerosis.

The answer

Answered by Shona Robison on 24 Feb 2010 · 23 days after it was lodged, on time

I refer the member to the answer to question S3W-31365 on 24 February 2010. All answers to written parliamentary questions are available on the Parliament''s website, the search facility for which can be found at http://www.scottish.parliament.uk/Apps2/Business/PQA/Default.aspx.

"Ti

In the Official Report

No contribution in the Official Report cites S3W-31366 by reference.